Aisling Capital

Aisling Capital seeks to identify differentiated healthcare products, services, and technologies that address unmet medical needs. Our business is to provide promising companies with meaningful capital resources and to assist them in achieving their growth objectives. We identify healthcare companies at a stage in their development where an infusion of capital and strategic assistance will significantly enhance the opportunities for success.

Aisling Capital makes investment decisions driven by fundamental assessment of scientific, regulatory, financial, and commercial risks. Given our investment team’s broad skillset, we invest across the life sciences, including seed and venture financings of development-stage companies, small-cap publicly traded equities, structured debt and royalty deals, and large-cap leveraged buyouts of profitable companies.

Aisling Capital takes an active approach to investing, working closely with portfolio companies to help them become value-building enterprises with multiple opportunities for exit. Our investment professionals collaborate with management teams and contribute expertise and experience to help determine and execute strategy, identify and evaluate business opportunities, and address financial issues.